Opportunity Information: Apply for CDC RFA PS10 10181
Apply for CDC RFA PS10 10181
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Enhanced Comprehensive HIV Prevention Planning and Implementation for Metropolitan Statistical Areas Most Affected by HIV/AIDS" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.523 The Affordable Care Act Human Immunodeficiency Virus (HIV) Prevention and Public Health Fund Activities.
- This funding opportunity was created on Sep 1, 2010 and posted on Aug 13, 2010.
- Applicants must submit their applications by Sep 2, 2010. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $12,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $1,750,000.00 in funding.
- The number of recipients for this funding is limited to 12 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Applicants eligible to apply for this cooperative agreement are limited to twelve (12) entities in specific Metropolitan Statistical Areas (MSAs) or specified Metropolitan Divisions (MDs) that have the highest estimated AIDS prevalence at the end of 2007. These twelve eligible areas comprise 44 of the total estimated persons living with AIDS in the United States as of the end of 2007. The entities eligible to apply for funds under this FOA are as follows 1. New York City Department of Health and Mental Hygiene New York Division 2. Los Angeles County Public Health Department Los Angeles Division 3. District of Columbia Department of Mental Health Washington Division 4. Chicago Department of Public Health Chicago Division 5. Georgia Department of Human Resources Atlanta Sandy Springs Marietta, GA 6. Florida State Department of Health Miami Division 7. City of Philadelphia Public Health Department Philadelphia Division 8. Houston Department of Health and Human Services Houston Baytown Sugar Land, TX 9. San Francisco Department of Public Health San Francisco Division 10. Maryland State Department of Health Baltimore Towson, MD 11. Texas State Department of Health Services Dallas Division 12. Puerto Rico Department of Health San Juan Caguas Guaynabo, PR
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The CDC funding opportunity titled "Enhanced Comprehensive HIV Prevention Planning and Implementation for Metropolitan Statistical Areas Most Affected by HIV/AIDS" (Funding Opportunity Number CDC RFA PS10-10181) is a discretionary cooperative agreement designed to help the jurisdictions hit hardest by the HIV epidemic create and carry out more focused, higher-impact HIV prevention strategies. The central goal is to reduce HIV risk and new infections in the metropolitan areas with the greatest AIDS prevalence by strengthening how prevention, care, and treatment services are planned, coordinated, and delivered. Rather than supporting isolated activities, the program emphasizes building an "Enhanced Comprehensive HIV Prevention Plan" (ECHPP) that is driven by the best available evidence, tailored to local conditions, and supported with intensive technical guidance from HHS/CDC.
The program is structured in two phases. Phase I, funded under this specific announcement, has a one-year project period. During that year, grantees are expected to develop a focused ECHPP for their targeted metropolitan area and begin implementing the plan. The idea is that each jurisdiction uses data and evidence-based approaches to identify the most effective combination of services across the HIV continuum, including prevention interventions, linkage to care, retention in care, and treatment-related strategies that can reduce community viral load and ultimately prevent new transmissions. The plan is meant to be practical and implementation-ready, not just a planning document, with early implementation activities starting during the Phase I period.
Phase II is intentionally separated and would be funded under a different future FOA. After Phase I concludes, a subset of the Phase I jurisdictions would be selected through a competitive process to continue and expand implementation of their ECHPP over a two-year project period. In other words, Phase I is both a planning and initial rollout year, while Phase II is a more intensive implementation period reserved for selected jurisdictions that compete for the follow-on funding.
Funding for Phase I was substantial and targeted. The CDC anticipated 12 awards with an estimated total funding amount of $12,000,000. Individual award amounts were expected to fall between $750,000 (floor) and $1,750,000 (ceiling). There was no cost sharing or matching requirement. The funding falls under CFDA 93.523, The Affordable Care Act HIV Prevention and Public Health Fund Activities, aligning the opportunity with broader public health financing intended to strengthen prevention outcomes.
Eligibility was highly restricted and limited to 12 specific entities tied to the metropolitan statistical areas (MSAs) or metropolitan divisions (MDs) with the highest estimated AIDS prevalence as of the end of 2007. Collectively, these 12 areas represented 44 percent of the total estimated number of persons living with AIDS in the United States at that time, which explains the program's concentrated focus on places where investments could have outsized impact. The eligible applicants were the following public health authorities: New York City Department of Health and Mental Hygiene (New York Division); Los Angeles County Public Health Department (Los Angeles Division); District of Columbia Department of Mental Health (Washington Division); Chicago Department of Public Health (Chicago Division); Georgia Department of Human Resources (Atlanta-Sandy Springs-Marietta, GA); Florida State Department of Health (Miami Division); City of Philadelphia Public Health Department (Philadelphia Division); Houston Department of Health and Human Services (Houston-Baytown-Sugar Land, TX); San Francisco Department of Public Health (San Francisco Division); Maryland State Department of Health (Baltimore-Towson, MD); Texas State Department of Health Services (Dallas Division); and Puerto Rico Department of Health (San Juan-Caguas-Guaynabo, PR).
Administratively, the opportunity was issued by the Centers for Disease Control and Prevention as a cooperative agreement, meaning the CDC intended to have substantial involvement in guiding the work rather than operating as a hands-off funder. Key dates included a posted date of August 13, 2010, with an original and current closing date of September 2, 2010, and an archive date of October 2, 2010. For applicants needing help accessing the full announcement, the CDC Procurement and Grants Office Technical Information Management Section (TIMS) was listed as the contact point via phone at 770-488-2700.
Frequently Asked Questions (FAQs)
What is the name of this CDC funding opportunity?
The opportunity is titled "Enhanced Comprehensive HIV Prevention Planning and Implementation for Metropolitan Statistical Areas Most Affected by HIV/AIDS."
What is the Funding Opportunity Number (FOA number)?
The Funding Opportunity Number is CDC RFA PS10-10181.
What type of funding mechanism is this?
This is a discretionary cooperative agreement. That means CDC intended to be substantially involved in guiding and providing technical direction for the funded work, rather than acting as a hands-off funder.
What is the main purpose of the program?
The purpose is to help the jurisdictions most affected by HIV/AIDS develop and carry out more focused, higher-impact HIV prevention strategies by strengthening how prevention, care, and treatment services are planned, coordinated, and delivered.
What is the central goal of the work funded under this program?
The central goal is to reduce HIV risk and new infections in the metropolitan areas with the greatest AIDS prevalence by improving planning and implementation across prevention, care, and treatment services.
What is an Enhanced Comprehensive HIV Prevention Plan (ECHPP)?
An ECHPP is the required plan that jurisdictions develop to guide focused, evidence-driven HIV prevention planning and implementation tailored to local conditions. The plan is meant to be practical and implementation-ready, not just a planning document.
How is this program different from funding isolated HIV prevention activities?
Rather than supporting stand-alone activities, the program emphasizes building and executing a comprehensive, evidence-based plan (the ECHPP) that coordinates strategies across the HIV continuum.
What kinds of strategies or service areas are expected to be addressed in the ECHPP?
The ECHPP is expected to identify an effective combination of services across the HIV continuum, including prevention interventions, linkage to care, retention in care, and treatment-related strategies intended to reduce community viral load and prevent new transmissions.
Is this opportunity structured in phases?
Yes. The program is structured in two phases: Phase I (funded under this announcement) and Phase II (to be funded under a separate future funding opportunity announcement).
What is the project period for Phase I?
Phase I has a one-year project period.
What are Phase I recipients expected to do during the one-year project period?
During Phase I, recipients are expected to develop a focused ECHPP for the targeted metropolitan area and begin implementing the plan during the Phase I period.
Does Phase I include implementation, or is it planning only?
Phase I is both a planning and initial rollout year. The plan is expected to be implementation-ready, with early implementation activities starting during the Phase I period.
How is Phase II described in the opportunity?
Phase II is described as a follow-on, more intensive implementation period with a two-year project period. It would be funded under a different future FOA and is not automatically awarded to Phase I recipients.
Is Phase II funding guaranteed for Phase I awardees?
No. After Phase I concludes, a subset of Phase I jurisdictions would be selected through a competitive process to continue and expand implementation in Phase II.
How many Phase I awards did CDC anticipate?
CDC anticipated 12 awards for Phase I.
What was the estimated total funding amount for Phase I?
The estimated total funding amount was $12,000,000.
What was the expected funding range for individual Phase I awards?
Individual awards were expected to range from $750,000 (floor) to $1,750,000 (ceiling).
Is there a cost sharing or matching requirement?
No. The opportunity states there was no cost sharing or matching requirement.
What CFDA number is associated with this opportunity?
The opportunity is listed under CFDA 93.523, The Affordable Care Act HIV Prevention and Public Health Fund Activities.
Who is eligible to apply for this funding?
Eligibility was highly restricted to 12 specific public health authorities tied to the metropolitan statistical areas (MSAs) or metropolitan divisions (MDs) with the highest estimated AIDS prevalence as of the end of 2007.
Which jurisdictions were eligible applicants?
The eligible applicants listed were:
- New York City Department of Health and Mental Hygiene (New York Division)
- Los Angeles County Public Health Department (Los Angeles Division)
- District of Columbia Department of Mental Health (Washington Division)
- Chicago Department of Public Health (Chicago Division)
- Georgia Department of Human Resources (Atlanta-Sandy Springs-Marietta, GA)
- Florida State Department of Health (Miami Division)
- City of Philadelphia Public Health Department (Philadelphia Division)
- Houston Department of Health and Human Services (Houston-Baytown-Sugar Land, TX)
- San Francisco Department of Public Health (San Francisco Division)
- Maryland State Department of Health (Baltimore-Towson, MD)
- Texas State Department of Health Services (Dallas Division)
- Puerto Rico Department of Health (San Juan-Caguas-Guaynabo, PR)
Why was eligibility limited to those 12 areas?
The opportunity explains that these 12 areas represented 44 percent of the total estimated number of persons living with AIDS in the United States as of the end of 2007, so the program focused resources where investments could have an outsized impact.
Which federal agency issued the opportunity?
The opportunity was issued by the Centers for Disease Control and Prevention (CDC).
When was the opportunity posted?
The posted date was August 13, 2010.
What was the application closing date?
The original and current closing date listed was September 2, 2010.
When was the opportunity archived?
The archive date was October 2, 2010.
Where could applicants get help accessing the full announcement?
Applicants needing help accessing the full announcement were directed to the CDC Procurement and Grants Office Technical Information Management Section (TIMS).
What is the contact phone number provided for TIMS?
The phone number listed for TIMS was 770-488-2700.
What role was CDC expected to play during the project?
Because this was a cooperative agreement, CDC expected to have substantial involvement, including providing intensive technical guidance to support development and implementation of the ECHPP.
What is the intended outcome of strengthening planning, coordination, and delivery of services?
The intended outcome is fewer new HIV transmissions, supported by a stronger combination of prevention, care linkage, retention, and treatment strategies that can reduce community viral load.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: State Competitive Supplemental Funding for Behavioral Risk Factor Surveillance System
Previous opportunity: State of Idaho Transboundary Decision Support System for Conservation, Land Use, Energy, Transportation, and Climate Change
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA PS10 10181
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA PS10 10181) also looked into and applied for these:
| Funding Opportunity |
|---|
| State Competitive Supplemental Funding for Behavioral Risk Factor Surveillance System Apply for CDC RFA DP09 90103 SUPP10 Funding Number: CDC RFA DP09 90103 SUPP10 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Limited Pilot for NIGMS Legacy Community Wide Scientific Resources (R24) Apply for PAR 10 261 Funding Number: PAR 10 261 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Scalable Assays for Unbiased Analysis of Neurobiological Function (R01) Apply for RFA MH 11 040 Funding Number: RFA MH 11 040 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Ryan White Part A HIV Emergency Relief Grant Program Apply for HRSA 11 062 Funding Number: HRSA 11 062 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Planning Grant for Global Infectious Disease Research Training Program (D71) Apply for PAR 10 262 Funding Number: PAR 10 262 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Behavioral Mechanisms in Biomedical Strategies to Prevent HIV Infections (R34) Apply for RFA MH 11 092 Funding Number: RFA MH 11 092 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Behavioral Mechanisms in Biomedical Strategies to Prevent HIV Infections (R01) Apply for RFA MH 11 090 Funding Number: RFA MH 11 090 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Behavioral Mechanisms in Biomedical Strategies to Prevent HIV Infections (R21) Apply for RFA MH 11 091 Funding Number: RFA MH 11 091 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Reinvigorating HIV Prevention for Men who have Sex with Men (R01) Apply for RFA MH 11 080 Funding Number: RFA MH 11 080 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Reinvigorating HIV Prevention for Men who have Sex with Men (R21) Apply for RFA MH 11 081 Funding Number: RFA MH 11 081 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Reinvigorating HIV Prevention for Men who have Sex with Men (R34) Apply for RFA MH 11 082 Funding Number: RFA MH 11 082 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Program to Expand and Assess the Health Effects Associated with Exposures to Volcanic Emission and Air Pollutants Apply for RFA EH08 0010301SUPP10 Funding Number: RFA EH08 0010301SUPP10 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $80,000 |
| Diagnosis and Management of Severe Febrile Illness Apply for USAID TANZANIA 10 010 RFA Funding Number: USAID TANZANIA 10 010 RFA Agency: Tanzania USAID Dar es Salaam Category: Health Funding Amount: $24,000,000 |
| Identification of Immune Mediated Causes of Sensorineural Hearing Loss (R21/R33) Apply for RFA DC 11 002 Funding Number: RFA DC 11 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Affordable Care Act (ACA) Infrastructure to Expand Access to Care Program Apply for HRSA 11 126 Funding Number: HRSA 11 126 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| National Indian Health Outreach and Education Apply for HHS 2010 IHS NIHOE 0001 Funding Number: HHS 2010 IHS NIHOE 0001 Agency: Indian Health Service Category: Health Funding Amount: $340,000 |
| Support of NIGMS Program Project Grants (P01) Apply for PAR 10 266 Funding Number: PAR 10 266 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Asthma in Older Adults (R01) Apply for PA 10 263 Funding Number: PA 10 263 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Asthma in Older Adults (R21) Apply for PA 10 264 Funding Number: PA 10 264 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Asthma in Older Adults (R03) Apply for PA 10 265 Funding Number: PA 10 265 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA PS10 10181", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.